Quarterly report pursuant to Section 13 or 15(d)

Accrued expenses and other current liabilities

v3.24.1.1.u2
Accrued expenses and other current liabilities
3 Months Ended
Mar. 31, 2024
Accrued expenses and other current liabilities  
Accrued expenses and other current liabilities

Note 10 Accrued expenses and other current liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

March 31, 

December 31, 

    

2024

    

2023

Accrued clinical and development expenditure

$

12,049

$

12,351

Accrued employee expenses

6,248

13,226

VAT payable

1,398

Other accrued expenditure

4,113

3,277

Other

 

640

 

51

$

23,050

$

30,303